Lv12
8 积分 2021-03-18 加入
Suvorexant enhances oxycodone-induced respiratory depression in male rats
1小时前
待确认
Effects of suvorexant on diurnal cortisol and patient-reported stress during opioid withdrawal in a randomized trial
3小时前
已完结
Effects of suvorexant on diurnal cortisol and patient-reported stress during opioid withdrawal in a randomized trial
3小时前
已完结
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
1天前
已完结
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males
1天前
已完结
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
1个月前
已完结
Computational Analysis of the Fully Activated Orexin Receptor 2 across Various Thermodynamic Ensembles with Surface Tension Monitoring and Markov State Modeling
1个月前
已完结
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males
3个月前
已完结
Current and Emerging Prodrug Strategies
3个月前
已完结
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males
5个月前
已完结
皖公网安备34019202002308
